We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NCKL:IDXPT Trimegah Bangun Persada Tbk Analysis

Data as of 2026-09-01 - not real-time

IDR 950.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind PT Trimegah Bangun Persada Tbk is neutral at IDR 950.00, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 12.4%. With RSI at 56.1 the momentum picture is neutral, alongside a bearish MACD signal. Watch IDR 900.00 as support and IDR 990.00 as the nearer resistance level.
Multiples put this in undervalued territory at a P/E of 5.6. Analyst price targets sit 69.3% above the current price. Revenue is growing at 47.7% on a 32.7% profit margin. The 4.46% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 34.3%, a beta of 1.11 and a maximum drawdown of 49.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 6 out of 10.

Top Market Events

PT Trimegah Bangun Persada Tbk NCKL atau Harita Nickel mencatatkan pendapatan sebesar Rp17,1 triliun pada semester...KONTAN.CO.ID - JAKARTA. Emiten produsen nikel, PT Trimegah Bangun Persada Tbk NCKL meraih kinerja keuangan positif...Hosted on MSN3monRogoh kocek Rp 1 triliun, Trimegah Bangun Persada NCKL siap gelar buyback sahamKONTAN.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 1075.92
  • MACD momentum is negative
  • 30-day price change of +12.4%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 1075.92
  • Analyst targets imply +69.3% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Analyst targets imply +69.3% versus the current price
  • Profit margin of 32.7% is healthy
  • Revenue growth of +47.7%

Key Metrics & Analysis

Financial Health

Revenue Growth47.70%
Profit Margin32.67%
P/E Ratio5.6
ROE26.02%
ROA7.74%
Debt/Equity16.87
P/B Ratio1.4
Op. Cash FlowIDR5174.9B
Free Cash FlowIDR2565.9B

Technical Analysis

TrendNeutral
RSI56.1
SupportIDR 900.00
ResistanceIDR 990.00
MA 20IDR 941.25
MA 50IDR 880.70
MA 200IDR 1,075.93
MACDBearish
VolumeStable
Fear & Greed Index93.05

Valuation

Fair ValueIDR 1,350.16
Target PriceIDR 1,608.55
Upside/Downside69.32%
GradeUndervalued
TypeValue
Dividend Yield4.46%

Risk Assessment

Beta1.11
Volatility34.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.